Short Interest in Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Grows By 1,294.2%

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the target of a significant growth in short interest during the month of April. As of April 30th, there was short interest totaling 25,208 shares, a growth of 1,294.2% from the April 15th total of 1,808 shares. Based on an average daily trading volume, of 10,871 shares, the short-interest ratio is presently 2.3 days.

Cardio Diagnostics Price Performance

CDIOW opened at $0.01 on Tuesday. The firm has a 50 day moving average price of $0.02 and a 200-day moving average price of $0.02. Cardio Diagnostics has a twelve month low of $0.01 and a twelve month high of $0.07.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.